Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

Desai, Ami V ; Robinson, Giles W ; Gauvain, Karen ; Basu, Ellen M ; Macy, Margaret E ; Maese, Luke ; Whipple, Nicholas S ; Sabnis, Amit J ; Foster, Jennifer H ; Shusterman, Suzanne ; Yoon, Janet ; Weiss, Brian D ; Abdelbaki, Mohamed S ; Armstrong, Amy E ; Cash, Thomas ; Pratilas, Christine A ; Corradini, Nadège ; Marshall, Lynley V ; Farid-Kapadia, Mufiza ; Chohan, Saibah ; Devlin, Clare ; Meneses-Lorente, Georgina ; Cardenas, Alison ; Hutchinson, Katherine E ; Bergthold, Guillaume ; Caron, Hubert ; Chow Maneval, Edna ; Gajjar, Amar ; Fox, Elizabeth

Neuro-oncology (Charlottesville, Va.), 2022-10, Vol.24 (10), p.1776-1789 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível